Pediatrix Medical Group, Inc. MD
31.38 USD -0.07 (-0.24%)
Nov 12, 2026, 11:37 AM EST
31.09 Day range 31.96
17.23 52-week range 33.74
- YTD
- +46.68%
- 1 year
- +38.28%
News
benzinga.com Mizuho Downgrades Pediatrix Medical Group to Underperform, Maintains Price Target to $28 Mizuho analyst Ann Hynes downgrades Pediatrix Medical Group (NYSE:MD) from Neutral to Underperform and maintains the price target from $28 to $28.
zacks.com What Makes Pediatrix Medical Group (MD) a Strong Momentum Stock: Buy Now? Does Pediatrix Medical Group (MD) have what it takes to be a top stock pick for momentum investors? Let's find out.
zacks.com Pediatrix Medical Group (MD) Upgraded to Buy: Here's What You Should Know Pediatrix Medical Group (MD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
zacks.com Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
benzinga.com Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $31 Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $28 to $31.
benzinga.com Pediatrix Medical Group Q3 2026 Earnings Call Transcript Pediatrix Medical Group (NYSE:MD) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
benzinga.com Pediatrix Medical Group Q3 Adj. EPS $0.72 Beats $0.65 Estimate, Sales $501.374M Beat $498.144M Estimate Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.72 per share which beat the analyst consensus estimate of $0.65 by 10.77 percent. This is a 7.46 percent increase over earnings of…
benzinga.com This Baidu Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday Wall Street analysts change outlook on top stocks, including BIDU and BMO. See their ratings and price targets on Benzinga's analyst page.- benzinga.com Jefferies Downgrades Pediatrix Medical Group to Hold, Raises Price Target to $28 Jefferies analyst Jack Slevin downgrades Pediatrix Medical Group (NYSE:MD) from Buy to Hold and raises the price target from $27 to $28.
benzinga.com UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $28 UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $25 to $28.
benzinga.com Full Transcript: Pediatrix Medical Group Q2 2026 Earnings Call Pediatrix Medical Group (NYSE:MD) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For…- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday's pre-market session. The company's market cap stands at $4.3 million. Adagio Medical Holdings…
benzinga.com Pediatrix Medical Group Q2 Adj. EPS $0.63 Beats $0.59 Estimate, Sales $487.783M Beat $478.449M Estimate Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.59 by 6.78 percent. This is a 18.87 percent increase over earnings of…- benzinga.com Pediatrix Reports Q2 Payor Mix Remains Stable, No Material Changes In Net Revenue Trends; Reaffirms FY26 Adj EBITDA Outlook Of $280M-$300M Pediatrix Medical Group, Inc. (NYSE:MD) ("Pediatrix" or "the Company"), a leading provider of physician services, today provided an update on its second quarter 2026 business trends.In response to…
benzinga.com Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $28 Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $23 to $28.
benzinga.com Under the Radar: 5 Small-Cap Stocks Wall Street Is Missing One of the biggest mistakes investors make is spending all their time looking for what is cheap and almost no time looking for what is working. Do not get me wrong. I love cheap stocks. Anyone who…
benzinga.com Pediatrix Medical Group Publishes New Research On Probiotic Use And Necrotizing Enterocolitis In Preterm Infants Pediatrix® Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced the publication of new research on probiotic use and necrotizing enterocolitis (NEC) in preterm…
benzinga.com UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $25 UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $22 to $25.
benzinga.com Transcript: Pediatrix Medical Group Q1 2026 Earnings Conference Call 
benzinga.com Earnings Scheduled For May 5, 2026 - benzinga.com Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $23 Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $21 to $23.
benzinga.com Mach Natural Resources, Mesoblast And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session U.S. stock futures down, Nasdaq 100 falls over 100 points. Mach Natural Resources LP (MNR) shares dip 7.6% in pre-market trading.- benzinga.com Pediatrix Medical Group Expands Tennessee Footprint Through Collaboration With Tennessee Maternal-Fetal Medicine Pediatrix® Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today announced its expansion in Middle Tennessee through a partnership with Tennessee Maternal-Fetal Medicine,…
- benzinga.com UBS Maintains Neutral on Pediatrix Medical Group, Lowers Price Target to $22 UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and lowers the price target from $23 to $22.
benzinga.com Truist Securities Maintains Hold on Pediatrix Medical Group, Lowers Price Target to $21 Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and lowers the price target from $24 to $21.- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga.com Earnings Scheduled For February 19, 2026
- benzinga.com Pediatrix Medical Group Q4 Adj. EPS $0.50 Misses $0.54 Estimate, Sales $493.771M Beat $486.228M Estimate Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.50 per share which missed the analyst consensus estimate of $0.54 by 7.24 percent. This is a 1.96 percent decrease over earnings of…
benzinga.com Earnings Outlook For Pediatrix Medical Group - benzinga.com Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $24 Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $17 to $24.
- benzinga.com UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $23 UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $16.5 to $23.
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com Earnings Scheduled For November 3, 2025 - benzinga.com Pediatrix Medical Group Q3 Adj. EPS $0.67 Beats $0.47 Estimate, Sales $492.875M Beat $476.493M Estimate Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.67 per share which beat the analyst consensus estimate of $0.47 by 43.78 percent. This is a 52.27 percent increase over earnings of…
- benzinga.com Leerink Partners Maintains Market Perform on Pediatrix Medical Group, Raises Price Target to $17 Leerink Partners analyst Whit Mayo maintains Pediatrix Medical Group (NYSE:MD) with a Market Perform and raises the price target from $14.5 to $17.
- benzinga.com Pediatrix Medical Group Authorizes $250M Share Repurchase Program Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced that its Board of Directors has authorized a share repurchase program of up to $250 million of the…
- benzinga.com UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $16.5 UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $16 to $16.5.
- benzinga.com Pediatrix Medical Group Q2 Adj. EPS $0.53 Beats $0.42 Estimate, Sales $468.844M Beat $464.324M Estimate Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.53 per share which beat the analyst consensus estimate of $0.42 by 24.71 percent. This is a 55.88 percent increase over earnings of…
- benzinga.com Earnings Scheduled For August 5, 2025
- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
- benzinga.com UBS Maintains Neutral on Pediatrix Medical Group, Lowers Price Target to $16 UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and lowers the price target from $18.5 to $16.
- benzinga.com Expert Outlook: Pediatrix Medical Group Through The Eyes Of 4 Analysts
- benzinga.com Macquarie Maintains Outperform on Pediatrix Medical Group, Raises Price Target to $20 Macquarie analyst Tao Qiu maintains Pediatrix Medical Group (NYSE:MD) with a Outperform and raises the price target from $19 to $20.
- benzinga.com Pediatrix Medical Group Q1 Adj. EPS $0.33 Beats $0.24 Estimate, Sales $458.36M Beat $451.50M Estimate Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.24 by 37.5 percent. This is a 65 percent increase over earnings of…
benzinga.com Earnings Scheduled For May 6, 2025 - benzinga.com Truist Securities Maintains Hold on Pediatrix Medical Group, Lowers Price Target to $16 Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and lowers the price target from $18 to $16.
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com Beyond The Numbers: 4 Analysts Discuss Pediatrix Medical Group Stock
- benzinga.com UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $18.5 UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $16.5 to $18.5.
- benzinga.com Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $18 Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $15 to $18.